Trxade Group, Inc.

The momentum for this stock is not very good. Trxade Group, Inc. is not very popular among insiders. Trxade Group, Inc. is a mediocre stock to choose.

News

TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team

Globe Newswire TAMPA, FL and COMMACK, NY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. ( TRxADE ) (NASDAQ: MEDS) and Scienture, LLC ( Scienture ), a wholly owned subsidiary of TRxADE, today announced the...\n more…

Trxade Health acquires Scienture in all-stock transaction valued at $103M

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million

Globe Newswire Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction valued at $103 million. TAMPA, FL...\n more…

Trxade Health announces special cash dividend of $1.50 per share

TRxADE Health, Inc. Announces Special Cash Dividend

Globe Newswire TAMPA, FL, July 09, 2024 (GLOBE NEWSWIRE) -- TRxADE HEALTH, INC. (Nasdaq: MEDS) (the Company ), announced that the Company's board of directors has declared a special cash dividend of $1.50 per...\n more…